Ganglioneuroblastoma Nodular clinical trials

Explore recruiting ganglioneuroblastoma nodular clinical trials.

Recruiting ganglioneuroblastoma nodular studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Ganglioneuroblastoma Nodular trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A Phase II Study of Naxitamab Added to Induction Therapy for Subjects with Newly Diagnosed High-Risk Neuroblastoma

Spain

Therapeutic exploratory (Phase II) EU CTIS Study details

Ganglioneuroblastoma Nodular trials by city

Ganglioneuroblastoma Nodular in Toronto Ganglioneuroblastoma Nodular in Vancouver Ganglioneuroblastoma Nodular in Montreal Ganglioneuroblastoma Nodular in Calgary Ganglioneuroblastoma Nodular in Edmonton Ganglioneuroblastoma Nodular in Ottawa Ganglioneuroblastoma Nodular in Winnipeg Ganglioneuroblastoma Nodular in Quebec City Ganglioneuroblastoma Nodular in Hamilton Ganglioneuroblastoma Nodular in Kitchener Ganglioneuroblastoma Nodular in London Ganglioneuroblastoma Nodular in Halifax Ganglioneuroblastoma Nodular in New York Ganglioneuroblastoma Nodular in Los Angeles Ganglioneuroblastoma Nodular in Chicago Ganglioneuroblastoma Nodular in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease